• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconModerna

Moderna

Page 17 of 18
HealthPfizer, BioNTech plan filing as COVID trials show their vaccine is 95% effective
By Robert Langreth and BloombergNovember 18, 2020
NewslettersHere are the most bullish trades for 2021—and, no, Bitcoin does not top the list
By Bernhard WarnerNovember 18, 2020
Empty seats are seen in terminal 1 at the "Berlin Brandenburg Airport Willy Brandt" in Schoenefeld, south-east of Berlin, on November 6, 2020. - British lowcost airline Easyjet announced on November 6, 2020, that it was reducing its flight capacity for the first quarter of 2021 to "at most 20%" of what it initially planned for this period, in reaction to the containment measures announced across Europe to combat the Covid-19 pandemic/
FinanceAirlines saw an immediate boost in passenger bookings following vaccine announcements
By David MeyerNovember 17, 2020
NewslettersVaccine breakthroughs are unleashing a ‘value rally.’ Here’s what investors should know
By Bernhard WarnerNovember 17, 2020
HealthModerna says its COVID-19 vaccine is 94.5% effective
By Robert Langreth and BloombergNovember 16, 2020
HealthModerna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
By Robert Langreth and BloombergNovember 12, 2020
NewslettersThe vaccine jolt fades, sinking global stocks—except for this one surprising sector
By Bernhard WarnerNovember 12, 2020
Medical syringe is seen with 'covid-19' sign displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
HealthAs COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By David MeyerOctober 15, 2020
Photo of CEPI Deputy Director Frederik Kristensen
HealthWhich COVID-19 vaccine works best? A new lab network promises an answer
By Jeremy KahnOctober 6, 2020
Vials of AstraZeneca's Covid-19 vaccine.
HealthWith AstraZeneca’s COVID-19 vaccine trials on hold in the U.S., a gulf widens between America and other countries
By Jeremy KahnOctober 2, 2020
Magazine‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma
By Clifton LeafSeptember 21, 2020
Image of a syringe injecting a coronavirus in front of an American flag.
HealthTrump wants a COVID-19 vaccine by Election Day. But will one be ready?
By Jeremy KahnSeptember 4, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca denies it is in discussions to fast-track U.S. approval of its COVID-19 vaccine
By Jeremy KahnAugust 24, 2020
Oxford-Vaccine-Trials-Kaiser-Health-News
HealthOxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing
By Jay Hancock, Kaiser Health NewsAugust 24, 2020
MagazineHow reborn pharma giant AstraZeneca is taking the lead against COVID-19
By Jeremy KahnAugust 10, 2020
1...
  • 14
  • 15
  • 16
  • 17
  • 18
18
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.